Placebo in functional dyspepsia: Symptomatic, gastrointestinal motor, and gastric sensorial responses

American Journal of Gastroenterology

Volumn 94, Issue 1, 1999, Pages 116-125

  Mearin, Fermín ^a   Balboa, Agustín ^a   Zárate, Natalia ^a   Cucala, Mercedes ^a   Malagelada, Juan R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPEPSIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MOTILITY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH INNERVATION; STOMACH MOTILITY; STOMACH PAIN; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; DYSPEPSIA; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; MALE; MANOMETRY; MIDDLE AGED; PLACEBOS; PRESSURE; SENSORY THRESHOLDS; STOMACH;

EID: 0032953860     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.00781.x     Document Type: Article

References (66)

1. Barbara L., Camilleri M., Corinaldesi R., et al. Definition and investigation of dyspepsia. Dig Dis Sci. 34:1989;1272-1276.
2. Talley N.J., Colin-Jones D., Koch K.L., et al. Functional dyspepsia A classification with guidelines for diagnosis and management . Gastroenterol Int. 4:1991;145-160.
3. Talley N.J. Drug treatment of functional dyspepsia. Scand J Gastroenterol. 26:(suppl):1991;47-60.
4. Veldhuyzen van Zanten S.J.O., Cleary C., Talley N.J., et al. Drug treatment of functional dyspepsia A systematic analysis of trial methodology with recommendations for design of future trials . Am J Gastroenterol. 91:1996;660-673.
5. Talley N.J., Phillips S.F. Nonulcer dyspepsia Potential causes and pathophysiology . Ann Intern Med. 108:1988;865-879.
6. Levinde J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 2:1978;654-657.
7. Evans F.J. Expectancy, therapeutic instructions and the placebo response. White L., Tursky B., Schwartz G.E. Placebo: Theory, research, and mechanisms. 1985;215-228 Guilford Press, New York.
8. Gracely R.H. Verbal descriptor measures of pain clarify mechanisms of analgesia due to narcotics brain stimulation and placebo. Anesth Prog. 34:1987;113-127.
9. Grevert P., Goldstein A. Placebo analgesia, naloxone, and the role of endogenous opiods. White L., Tursky B., Schwartz G.E. Placebo research, and mechanisms. 1985;333-350 Ford Press, New York.
10. Bennett E., Beaurepair J., Langeluddecke P., et al. Life stress and non-ulcer dyspepsia A case-control study . J Psychosom Res. 35:1991;579-590.
11. Magni G., et al. DSM-III diagnoses associated with dyspepsia of unknown cause. Am J Psychiatry. 144:1987;1222-1223.
12. Camilleri M., Malagelada J.R., Kao P.C., et al. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci. 31:1986;1169-1177.
13. Ford M.J., Camilleri M., Zinsmeister A.R., et al. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology. 109:1995;1772-1780.
14. Mearin F., Malagelada J-R. Upper gut motility and perception in functional dyspepsia. Eur J Gastroenterol Hepatol. 4:1992;615-621.
15. Mearin F., Cucala M., Azpiroz F., et al. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology. 101:1991;999-1006.
16. Malagelada J.-R., Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology. 88:1985;1223-1231.
17. Arndorfer R.C., Stef J.J., Dodds W.J., et al. Improved infusion system for intraluminal esophageal manometry. Gastroenterology. 73:1977;23-27.
18. Azpiroz F., Malagelada J-R. Physiologic variations in canine gastric tone measured by an electronic barostat. Am J Physiol. 248:1985;G229-G237.
19. Azpiroz F., Malagelada J-R. Gastric tone measured an electronic barostat in health and postsurgical gastroparesis. Gastroenterology. 92:1987;934-943.
20. Azpiroz F., Malagelada J-R. Isobaric intestinal distensions in humans Sensorial relay and reflex gastric relaxation . Am J Physiol. 258:1990;202-207.
21. Azpiroz F., Malagelada J-R. Perception and gastric relaxation of the stomach in response to gut distension. Gastroenterology. 98:1990;1193-1198.
22. Stanghellini V., Camilleri M., Malagelada J-R. Chronic idiopathic intestinal pseudo-obstruction Clinical and intestinal manometric findings . Gut. 28:1987;5-12.
23. Deruyttere M., Lepoutre L., Heylen H., et al. Cisapride in the management of chronic functional dyspepsia A multicenter, double-blind, placebo-controlled study . Clin Ther. 10:1987;44-51.
24. François J., De Nutte N. Nonulcer dyspepsia Effect of the gastrointestinal prokinetic drug cisapride . Curr Ther Res. 41:1987;891-898.
25. Hannon R. Efficacy of cisapride in patients with nonulcer dyspepsia. A placebo controlled study. Curr Ther Res. 42:1987;814-822.
26. Kelbaek H., Linde J., Eriksen J., et al. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand. 217:1985;281-287.
27. Nyren O., Adam H.O., Bates S., et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med. 314:1986;339-343.
28. Goethals C., Van de Mierop L. Cisapride in the treatment of chronic functional dyspepsia. Results of a double-blind placebo-controlled crossover study. Curr Ther Res. 42:1987;261-267.
29. Rösch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol. 22:1987;161-164.
30. De Nutte N., Van Ganse W., Witterhulghe M., et al. Relief of epigastric pain in nonulcer dyspepsia. Controlled trial of the promotility drug cisapride. Clin Ther. 11:1989;62-68.
31. Hausken T., Berstad A. Wide gastric antrum with non-ulcer dyspepsia. Effect of cisapride. Scand J Gastroenterol. 27:1992;213-217.
32. Bekhti A., Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J. 55:(suppl 1):1979;30-32.
33. Van de Mierop L., Rutgeerts L., Van den Langembergh B., et al. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion. 19:1979;244-250.
34. Delattre M., Malesky M., Prinzie A. Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Curr Ther Res. 37:1985;980-991.
35. Nesland A., Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol. 20:1985;629-635.
36. Lance P., Wastell C., Schiller K. A controlled trial of cimetidine for the treatment of nonulcer dyspepsia. J Clin Gastroenterol. 8:1986;414-418.
37. Singal A.K., Kumar A., Broor S.L. Cimetidine in the treatment of non-ulcer dyspepsia. Results of a randomized double-blind, placebo controlled study. Curr Med Res Opin. 11:1989;390-397.
38. Hradsky M., Wikander M. Effect of pirenzipine in the treatment of non-ulcer dyspepsia. A double-blind study. Scand J Gastroenterol. 17:1983;251-252.
39. Weberg R., Berstad A. Low-dose antacids and pirenzipine in the treatment of patients with nonulcer dyspepsia and erosive prepyloric chances. A randomized, double blind, placebo-controlled trial. Scand J Gastroenterol. 23:1988;237-243.
40. Smith P.M., Troughton A.H., Gleeson F., et al. Pirenzepine in non-ulcer dyspepsia A double-blind multicentre trial . J Int Med Res. 18:1990;16-20.
41. Kairaluoma M., Hentilse R., Alavaikko M., et al. Sucralfate versus placebo in treatment of non-ulcer dyspepsia. Am J Med. 83:1987;51-55.
42. Hui W.M., Lam S.K., Lok A.S.F., et al. Sulpiride improves functional dyspepsia A double-blind controlled study . J Gastroenterol Hepatol. 1:1986;391-399.
43. Walters J.M., Crean P., McCarthy C.F. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Irish J Med. 73:1980;380-381.
44. Lambert J., Dunn K., Borromeo M., et al. Campylobacter pylori A role in non-ulcer dyspepsia . Scand J Gastroenterol. 24:1989;7-13.
45. Loffeld R.J., Potters H.V., Stobberingh E., et al. Campylobacter-associated gastritis in patients with non-ulcer dyspepsia A double-blind, placebo controlled trial with colloidal bismuth subcitrate . Gut. 30:1989;1206-1212.
46. Hausken T., Stene-Larsen G., Lange O., et al. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study. Scand J Gastroenterol. 25:1990;1028-1033.
47. Kellow J.E., Cowan H., Shuter B., et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther. 9:1995;153-160.
48. Chung J.M. Cisapride in chronic dyspepsia Results of a double-blind, placebo-controlled trial . Scand J Gastroenterol. 195:(suppl):1993;11-14.
49. Gothard R., Bodemar G., Brodin U., et al. Treatment with cimetidine, antacids, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol. 23:1988;7-18.
50. Mac Kinnon M., Willing R.L., Whitehead R. Cimetidine in the management of symptomatic patients with duodenitis. A double-blind controlled trial. Dig Dis Sci. 27:1982;217-219.
51. Saunders J., Oliver R., Higson D. Dyspepsia Incidence of non-ulcer disease in a controlled trial of ranitidine in general practice . Br Med J. 292:1986;665-668.
52. Skoubo-Kristensen E., Funch-Jensen P., Kruse A., et al. Controlled clinical trial with sulcrafate in the treatment of macroscopic gastritis. Scand J Gastroenterol. 24:1989;716-720.
53. Kang J., Tay H., Wee A., et al. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double-blind, placebo-controlled study. Gut. 31:1990;476-480.
54. Van Ganse W., Van Damme L., Van de Mierop L., et al. Chronic dyspepsia: Double-blind treatment with domperidone (R 33 812) or a placebo. A multicentre therapeutic evaluation. Curr Ther Res. 23:1978;695-701.
55. DeLoose F. Domperidone in chronic dyspepsia A pilot open study and a multicentre general practice cross-over comparison with metoclopramide and placebo . Pharmatherapeutica. 2:1979;140-146.
56. Johnson A. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. Br Med J. 2:1971;25-26.
57. Van Outryve M., De Nutte N., Van Eeghem O., et al. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide A double-blind, placebo-controlled study . Scand J Gastroenterol. 195:(suppl):1993;47-52.
58. Max M.B., Culname M., Schafer S.C., et al. Amitripttyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 37:1987;589-596.
59. Diamond E.G., Kittle C.F., Crockett J.E. Comparison of internal mammary ligation and sham operation for angina pectoris. Am J Cardiol. 5:1960;483-486.
60. O'Donnell M. Our oath is hypocritical. Monitor Weekly. 156:1995;Mar 1-Mar44.
61. Grouios G. The placebo phenomenon Its effectiveness and modes of action in effort migraine . Med Sci Res. 24:1996;15-16.
62. Ho K.H., Hashish J., Salmon P., et al. Reduction of postoperative swelling by a placebo effect. J Psychosom Res. 32:1988;197-205.
63. Grevert P., Albert L.H., Goldstein A. Partial antagonism of placebo analgesia by naloxone. Pain. 16:1983;129-143.
64. Baber N.S., Dourish C.T., Hill D.R. The role of CCK, caerulein, and CCK antagonists in nociception. Pain. 39:1989;307-328.
65. Benedetti F., Amanzio M., Maggi G. Potentiation of placebo analgesia by proglumide. Lancet. 346:1995;1231.
66. Accarino A.M., Azpiroz F., Malagelada J-R. Attention and distraction Effects on gut perception . Gastroenterology. 113:1997;415-422.